TrialBlood2021
Phase 2 study of ibrutinib in classic and variant hairy cell leukemia.
Kerry A Rogers et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
41 papers cite it
this paperpooled ittrialcites it
TrialBlood2021
Kerry A Rogers et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.